G
$ Value
$0
Shares
2,249
Price
$0
Filed
Mar 5
Insider
Name
ABERNETHY MATT
Title
Chief Financial Officer
CIK
0001724097
Roles
Officer
Transaction Details
Transaction Date
2026-03-04
Code
G
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
42,808
Footnotes
This transaction represents a gift/charitable contribution effective March 4, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares. | Includes an aggregate of 176 shares purchased on February 27, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.
Filing Info
ABERNETHY MATT's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | NBIX | G | $0 |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $150K |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $172K |
| 2026-02-13 | NBIX | A | $0 |
| 2026-02-13 | NBIX | F | $668K |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | A | $0 |
Other Insiders at NBIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GORMAN KEVIN CHARLES | — | — | 2026-02-13 |
|
Lippoldt Darin
Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gano Kyle
Chief Executive Officer
|
— | — | 2026-02-13 |
|
BENEVICH ERIC
Chief Commercial Officer
|
— | — | 2026-02-13 |
|
ABERNETHY MATT
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Cooke Julie
Chief Human Resources Officer
|
— | — | 2026-02-13 |
|
Keswani Sanjay Chandru
Chief Medical Officer
|
— | — | 2026-02-13 |
|
Onyia Jude
Chief Scientific Officer
|
— | — | 2026-02-20 |
|
Boyer David W.
Chief Corp. Affairs Officer
|
— | — | 2026-02-13 |
|
Delaet Ingrid
Chief Regulatory Officer
|
— | — | 2026-02-13 |